BNTX - Spark Newswire

2 minute read

Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News

Today, 6:09 PM

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use of its Omicron-tar

BNTX

1 minute read

FDA Commissioner Robert Califf Says Updated Boosters Present Us With Opportunity To Get Ahead Of Next Predicated Wave Of Covid: Media Briefing

By Benzinga Newsdesk

Today, 6:09 PM

- Reuters

AZN

5 minute read

Pfizer And BioNTech Granted FDA Emergency Use Authorization Of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster For Ages 12 Years And Older

By Benzinga Newsdesk

Today, 6:09 PM

Authorization based on clinical, pre-clinical and manufacturing data for Omicron-adapted bivalent vaccines Pfizer-BioNTech Omicron BA.4/BA.5 bivalent vaccine combines 15-µg of mRNA encoding the wild-type

BNTX

1 minute read

Authorizes Moderna, Pfizer-BioNTech Bivalent Covid-19 Vaccines For Use As A Booster Dose

By Benzinga Newsdesk

Today, 6:09 PM

- U.S. FDA- U.S. FDA

BNTX

7 minute read

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30

By Akanksha Bakshi

Today, 6:09 PM

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

AAPL

3 minute read

Nasdaq Futures Fly As Wall Street Looks Set To Rebound From 2-Session Losses — Twitter, Best Buy And These Stocks In Focus

By Shanthi Rexaline

Today, 6:09 PM

U.S. stocks look set to see a turnaround on Tuesday, potentially reversing some of the losses incurred in the previous two trading sessions.

BBY

3 minute read

US Stock Futures Higher Ahead Of Economic Data, Fed Speakers

By Lisa Levin

Today, 6:09 PM

Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the Nasdaq Composite dropping around 1% in the previous session.

BBY

2 minute read

Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report

By Shanthi Rexaline

Today, 6:09 PM

Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.

BNTX

1 minute read

FDA
News

U.S. FDA Expected To Authorize A Pair Of Booster Shots Targeting What Appear To The Virus’ Most Contagious Strains As Soon As Wednesday

By Michael Horton

Today, 6:09 PM

-Reuters

BNTX

3 minute read

Recap Of Friday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 6:09 PM

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor…

BCRX

Feed Symbols: BNTX